Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cali Botanicals is a U.S.-based direct-to-consumer seller of kratom and related botanical products, with an online retail business focused on powders, capsules, extracts, and some CBD products. Publicly available information indicates the company operates as a commercial vendor rather than a biotechnology, pharmaceutical, or clinical-stage healthcare developer. The company appears to market consumer botanical products sourced from Southeast Asia and emphasizes product variety and retail distribution. FDA records show the business received a warning letter in 2019 regarding unapproved and misbranded kratom-containing products marketed with drug claims. Overall, Cali Botanicals is best characterized as a botanical e-commerce retailer, not a life sciences drug development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cali Botanicals.